Avaleht › Suur depressiivne häire › California
Suur depressiivne häire kliinilised uuringud osariigis California
52 uuringut haiguse Suur depressiivne häire jaoks otsivad osalejaid osariigis California.
Linnad osariigis California
- San Diego16 uuringut
- Orange13 uuringut
- Glendale12 uuringut
- Los Angeles12 uuringut
- Concord12 uuringut
- Oceanside9 uuringut
- San Bernardino8 uuringut
- San Francisco8 uuringut
- San Jose7 uuringut
- Mountain View7 uuringut
- Chino6 uuringut
- Bellflower6 uuringut
- Garden Grove4 uuringut
- Santa Monica4 uuringut
- Long Beach4 uuringut
- Burbank4 uuringut
- Anaheim3 uuringut
- Mission Viejo3 uuringut
- Downey3 uuringut
- Irvine3 uuringut
Ametlik uuringutekst (inglise keeles)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Irvine Clinical Research, Irvine
- Healthy Brain Clinic, Long Beach
- Oakland Clinical, Oakland
- ja veel 1
VärbamineFaas 3
Vanused 18–75 · Kõik sood · Uuendatud 1. okt 2026 · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- CI Trials, Bellflower
- Behavioral Research Specialists LLC, Glendale
- Excell Research Inc, Oceanside
- ja veel 3
VärbamineFaas 3
Vanused 18–74 · Kõik sood · Uuendatud 1. okt 2026 · NCT07573176Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- PAMOJA Clinical Institute LLC, Anaheim
- Axiom Research, Colton
- Behavioral Research Specialists LLC, Glendale
- ja veel 3
VärbamineFaas 3
Vanused 18–74 · Kõik sood · Uuendatud 25. sept 2026 · NCT06559306A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Buena Park Research Center, Buena Park
- Inland Psychiatric Medical Group, Inc. - Chino, Chino
- Synergy Research - San Diego, Lemon Grove
- ja veel 3
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT07621237Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- CNRI-Los Angeles, LLC, Pico Rivera
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 25. sept 2026 · NCT05850689A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Behavioral Research Specialists, LLC, Glendale
- CalNeuro Research Group, Los Angeles
- Lipov Medical Group, Los Angeles
- ja veel 4
VärbamineFaas 3
Vanused 18–85 · Kõik sood · Uuendatud 25. sept 2026 · NCT06793397Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Garden Grove
- Vanda Investigational Site, Orange
- Vanda Investigational Site, Redlands
- ja veel 2
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 24. sept 2026 · NCT06830044A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Chino
- Neurocrine Clinical Site, Fresno
- Neurocrine Clinical Site, Long Beach
- ja veel 3
VärbamineFaas 4
Vanused 18 ja vanemad · Kõik sood · Uuendatud 18. sept 2026 · NCT07105111Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression: A Home-Based Feasibility and Safety Study
- UCSD Interventional Psychiatry, San Diego
Värbamine
Vanused 18–85 · Kõik sood · Uuendatud 15. sept 2026 · NCT07217223A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Chino
- Seaport Investigator Site, Garden Grove
- Seaport Investigator Site, Glendale
- ja veel 2
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 14. sept 2026 · NCT07065240ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Inland Psychiatric Medical Group, Chino
- Behavioral Research Specialists, LLC, Glendale
- Kadima Neuropsychiatry Institute, La Jolla
- ja veel 1
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 14. sept 2026 · NCT07284667Near Infrared Spectroscopy (NIRS) for Assessment of Depression
- San Francisco Veterans Affairs Medical Center, San Francisco
VärbamineTerved vabatahtlikud oodatud
Vanused 18 ja vanemad · Kõik sood · Uuendatud 11. sept 2026 · NCT04061148A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Clinical Innovations Inc, Bellflower
- Center for Neurohealth, La Jolla
- Artemis Institute for Clinical Research, San Diego
- ja veel 1
VärbamineFaas 3
Vanused 18–74 · Kõik sood · Uuendatud 8. sept 2026 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Bellflower
- Draig Clinical Site, Costa Mesa
- Draig Clinical Site, Lafayette
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 2. sept 2026 · NCT07610473Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- USC University Hospital, Los Angeles
- UCLA Department of Psychiatry, Los Angeles
- University of California at Davis, Sacramento
Värbamine
Vanused 22–70 · Kõik sood · Uuendatud 28. aug 2026 · NCT06423430A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Oceanside
- Draig Clinical Site, San Diego
- Draig Clinical Site, Torrance
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 26. aug 2026 · NCT07300969Virtual Reality-Enhanced Behavioral Activation for Older Adults With Depression
- Stanford University, Stanford
Värbamine
Vanused 65 ja vanemad · Kõik sood · Uuendatud 21. aug 2026 · NCT07188623Enhancing Veteran-Clinical Collaboration in VA PRRCs
- VA San Diego Healthcare System, San Diego, CA, San Diego
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 19. aug 2026 · NCT06898879NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Glendale
- Neurocrine Clinical Site, Redlands
- Neurocrine Clinical Site, San Francisco
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 11. aug 2026 · NCT06911112Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS
- Stanford Hospital, Stanford
Värbamine
Vanused 18–80 · Kõik sood · Uuendatud 11. aug 2026 · NCT04870255Pain and Major Depressive Disorder
- UCLA Semel Institute, Los Angeles
VärbamineOsalejatele makstakse tasu
Vanused 18–75 · Kõik sood · Uuendatud 11. aug 2026 · NCT04556890A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- ATP Clinical Research Orange County, Orange
- Kadima Neuropsychiatry Institute, San Diego
- UCSF Department of Neurology, San Francisco
- ja veel 1
VärbamineFaas 3
Vanused 18–74 · Kõik sood · Uuendatud 10. aug 2026 · NCT07592689NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Chino
- Neurocrine Clinical Site, Los Angeles
- Neurocrine Clinical Site, Stanford
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 10. aug 2026 · NCT06963021A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Accellacare - Moorpark, Moorpark
- ATP Clinical Research, Orange
VärbamineFaas 3
Vanused 18–75 · Kõik sood · Uuendatud 6. aug 2026 · NCT07412756Closed-Loop Deep Brain Stimulation for Major Depression
- University of California, San Francisco, San Francisco
Värbamine
Vanused 22–70 · Kõik sood · Uuendatud 3. aug 2026 · NCT04004169A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Behavioral Research Specialists, Llc, Glendale
- Irvine Clinical Research, Irvine
- CalNeuro Research Group, Inc., Los Angeles
- ja veel 6
VärbamineFaas 3
Vanused 18–74 · Kõik sood · Uuendatud 3. aug 2026 · NCT06775379Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Irvine Clinical Research, Irvine
- CalNeuro Research Group, Los Angeles
- Sunwise Clinical Research LLC, Walnut Creek
VärbamineFaas 2
Vanused 18–64 · Kõik sood · Uuendatud 3. aug 2026 · NCT06547489A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Catalina Research Institute, LLC, Montclair
- Excell Research, Inc, Oceanside
- Anderson Clinical Research, Redlands
- ja veel 3
VärbamineFaas 2
Vanused 18–64 · Kõik sood · Uuendatud 27. juuli 2026 · NCT07115329A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Oceanside
- Neurocrine Clinical Site, Orange
- Neurocrine Clinical Site, San Jose
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 24. juuli 2026 · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Glendale
- Neurocrine Clinical Site, Los Angeles
- Neurocrine Clinical Site, Oceanside
- ja veel 5
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 24. juuli 2026 · NCT06966401Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Bellflower
- Clinical Research Site, Chino
- Clinical Research Site, Glendale
- ja veel 7
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 24. juuli 2026 · NCT07484217Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
- Acacia Clinics, Sunnyvale
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 16. juuli 2026 · NCT06376734Sleep TMS for Depression
- Stanford University, Stanford
VärbamineTerved vabatahtlikud oodatud
Vanused 18–65 · Kõik sood · Uuendatud 23. juuni 2026 · NCT06824415A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Advanced Research Center /ID# 277537, Anaheim
- Sun Valley Research Center /ID# 277513, Imperial
- Synergy San Diego /ID# 277553, Lemon Grove
- ja veel 4
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 15. juuni 2026 · NCT07276997Evaluating tDCS Brain-stimulation in Depression Using MRI
- University of California Los Angeles (UCLA), Los Angeles
Värbamine
Vanused 20–55 · Kõik sood · Uuendatud 8. juuni 2026 · NCT05598034A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- CenExel, Garden Grove
- Behavioral Research Specialists, LLC, Glendale
- Kadima Neuropsychiatry Institute, La Jolla
- ja veel 2
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 11. mai 2026 · NCT06524830Mindfulness Engaged Neurostimulation for Depression (MEND II)
- UC San Diego Health Psychiatry, San Diego
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 6. mai 2026 · NCT07512284Regulation of Affect and Physiology in Depression
- University of Southern California, Los Angeles
VärbamineFaas 2Terved vabatahtlikud oodatud
Vanused 18–27 · Kõik sood · Uuendatud 4. mai 2026 · NCT06345859Maintenance rTMS for Depression (Maitr-De)
- University of California, San Diego, San Diego
Värbamine
Vanused 18–80 · Kõik sood · Uuendatud 29. apr 2026 · NCT06938841ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
- Salma Health, La Jolla
- Salma Health, Laguna Hills
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Kõik sood · Uuendatud 14. apr 2026 · NCT07528014Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.